iifl-logo

Kerala Ayurveda Ltd Board Meeting

Add as a Preferred Source on Google
316.8
(-2.78%)
Jan 2, 2026|12:00:00 AM

Kerala Ayurveda CORPORATE ACTIONS

03/01/2025calendar-icon
03/01/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting17 Dec 202517 Dec 2025
1. The re-appointment of Ms. Shilpa Kiran Gududur (DIN: 09067581) for the second term of 5 (five) consecutive years, effective from 15thFebruary 2026 and valid till 14thFebruary2031,subject to approval of the members. 2. Issuance of Postal Ballot Notice for seeking shareholdersapproval for the following matters: a. Approval of creation of charge/lien over the assets of the company under section 180 (1)(a) of the Companies Act 2013. b. Approval of investments, provide loans, guarantees/letter of comfort/letterof support and security under section 186 of the Act. c. Approval for re-appointment of Ms. Shilpa Kiran Gududur (DIN: 09067581) for the second term of 5 (five) consecutive years.
Board Meeting14 Nov 202510 Nov 2025
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) for the quarter and half year ended 30th Sept.2025. Outcome of Board Meeting Financial Results for the quarter ended 30th September 2025 (As Per BSE Announcement Dated on:14.11.2025)
Board Meeting29 Aug 202529 Aug 2025
Outcome of Board meeting
Board Meeting18 Jul 202515 Jul 2025
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2025 inter alia to consider and approve the unaudited quarterly results for the quarter ended 30th June 2025 Outcome of Board meeting held on 18th July 2025 (As Per BSE Announcement dated on 18.07.2025)
Board Meeting26 May 202521 May 2025
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve the Audited Standalone and Consolidated Integrated Financial Results for the quarter and year ended 31st March 2025. outcome of the Board meeting (As per BSE Announcement Dated on 27/05/2025)
Board Meeting14 Feb 202510 Feb 2025
KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Integrated unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December 2024. Outcome of Board Meeting held on 14th Feb 2025 Outcome of Board Meeting held on 14th Feb 2025 (As Per BSE Announcement Dated on 14.02.2025) Integrated Filing (Financial) for the quarter ended 31st December, 2024. The company has already filed the Integrated Financial results for the quarter ended 31 st December, 2024 under the results Tab on 14th Feb 2025 (As per BSE Announcement Dated on 03/03/2025)

Kerala Ayurveda: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.